NVO Cash from Financing Activities - Cash Flow Statement - Novo Nordisk A/S - IntrinsicAlpha

Novo Nordisk A/S NVO

Healthcare - Biotechnology - NYSE - DK

$ 78.69

-5.27 %

$ 349 B

Market Cap

26.86

P/E

NVO - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities NVO - Novo Nordisk A/S

-63.2 B

LAST VALUE

-57.40%

2 YEAR CAGR

-12.84%

5 YEAR CAGR

-10.33%

10 YEAR CAGR